Extracellular Vesicles in Pathophysiology: A Prudent Target That Requires Careful Consideration
Cells · 2024
DOI: 10.3390/cells13090754 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, 2024. Verfasst von Sanjay Shahi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Chemistry, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC 3086, Australia. Hauptthemen laut MEDLINE: Extracellular Vesicles. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 281 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHMRC EL1 fellowship, CASS Foundation Medicine/Science, Jack Brockhoff Foundation Early Career Medical Research.
Abstract (Originalsprache)
Extracellular vesicles (EVs) are membrane-bound particles released by cells to perform multitudes of biological functions. Owing to their significant implications in diseases, the pathophysiological role of EVs continues to be extensively studied, leading research to neglect the need to explore their role in normal physiology. Despite this, many identified physiological functions of EVs, including, but not limited to, tissue repair, early development and aging, are attributed to their modulatory role in various signaling pathways via intercellular communication. EVs are widely perceived as a potential therapeutic strategy for better prognosis, primarily through utilization as a mode of delivery vehicle. Moreover, disease-associated EVs serve as candidates for the targeted inhibition by pharmacological or genetic means. However, these attempts are often accompanied by major challenges, such as off-target effects, which may result in adverse phenotypes. This renders the clinical efficacy of EVs elusive, indicating that further understanding of the specific role of EVs in physiology may enhance their utility. This review highlights the essential role of EVs in maintaining cellular homeostasis under different physiological settings, and also discusses the various aspects that may potentially hinder the robust utility of EV-based therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biochemistry and Chemistry, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC 3086, Australia.
ORCID-Profile: Sanjay Shahi
Förderung
- NHMRC EL1 fellowship
- CASS Foundation Medicine/Science
- Jack Brockhoff Foundation Early Career Medical Research
Zitieren
APA
Shahi, S., Kang, T., & Fonseka, P. (2024). Extracellular Vesicles in Pathophysiology: A Prudent Target That Requires Careful Consideration. Cells. https://doi.org/10.3390/cells13090754
Vancouver
Shahi S, Kang T, Fonseka P. Extracellular Vesicles in Pathophysiology: A Prudent Target That Requires Careful Consideration. Cells. 2024. doi:10.3390/cells13090754
BibTeX
@article{Shahi2024,
author = {Shahi, Sanjay and Kang, Taeyoung and Fonseka, Pamali},
title = {Extracellular Vesicles in Pathophysiology: A Prudent Target That Requires Careful Consideration},
journal = {Cells},
year = {2024},
doi = {10.3390/cells13090754}
}
EUVIMED